Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Microwave Ablation
... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More
-
Intrauterine Insemination
... at a CAGR of 7.9% over the analysis period 2023-2030. The U.S. Market is Estimated at US$441.0 Million While China is Forecast to Grow at 11.5% CAGR The Intrauterine Insemination market in the U.S. is ... Read More
-
Acne Drugs
... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Soft Tissue Repair
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Fixation Products, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.6 Billion by ... Read More
-
Acute Repetitive Seizures
... by 2030, growing at a CAGR of 44.7% over the analysis period 2023-2030. Diastat Rectal Gel, one of the segments analyzed in the report, is expected to record a 46.2% CAGR and reach US$8.4 Billion ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Neuroprotection Therapeutics
... at a CAGR of 6.9% over the analysis period 2023-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Restorative Dentistry
... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More
-
Sarcoma Drugs
... at a CAGR of 7.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Veterinary Orthopedics
... at a CAGR of 8.2% over the analysis period 2023-2030. Veterinary Orthopedics Implants, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$768.3 Million by the end ... Read More
-
Prosthetics and Orthotics
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Orthotics, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$7.5 Billion by the ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Hematological Malignancies
... at a CAGR of 6.2% over the analysis period 2023-2030. Leukemia Disease, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$33.3 Billion by the end of ... Read More
-
Hyperpigmentation Disorders Treatment
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by ... Read More
-
Ligament Stabilizers
... at a CAGR of 4.6% over the analysis period 2023-2030. Grade 1 Injury Stabilizers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.0 Billion by the ... Read More
-
Nephrology And Urology Devices
... reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More
-
Orthopedic Bone Cement
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$944.8 ... Read More
-
Patient Monitoring Devices
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More
-
Cervical Dysplasia Diagnostics
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by ... Read More
-
Embolotherapy
... of 7.5% over the analysis period 2023-2030. Embolic Agents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$6.7 Billion by the end of the analysis period. ... Read More
-
End-Stage Renal Disease
... by 2030, growing at a CAGR of 11.6% over the analysis period 2023-2030. Hemodialysis Treatment, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$209.9 Billion by ... Read More
-
Pediatric Imaging
... at a CAGR of 6.9% over the analysis period 2023-2030. Magnetic Resonance Imaging Modality, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$5.2 Billion by the ... Read More
-
Urology Lasers
... at a CAGR of 6.6% over the analysis period 2023-2030. Holmium Laser Type, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$749.4 Million by the end ... Read More
-
Dental Bioimplants
... at a CAGR of 7.4% over the analysis period 2023-2030. Plate Form Dental Implant, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$15.0 Billion by the ... Read More
Research Assistance
